Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-08-16 Sale | 2023-08-17 3:57 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer | 5,000 | $90 | $450,000 | 60,804 (Direct) | View |
2023-08-10 Sale | 2023-08-11 1:59 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D | 12,000 | $90.43 | $1,085,111 | 176,187 (Direct) | View |
2023-08-09 Sale | 2023-08-10 4:47 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer | 5,360 | $93.3 | $500,109 | 40,041 (Direct) | View |
2023-08-08 Sale | 2023-08-09 7:08 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer | 11,000 | $89.42 | $983,662 | 69,474 (Direct) | View |
2023-08-07 Sale | 2023-08-09 7:05 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 10,000 | $88.21 | $882,140 | 670,265 (Indirect Direct) | View |
2023-05-11 Sale | 2023-05-15 4:58 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 30,000 | $94.67 | $2,840,226 | 712,876 (Indirect Direct) | View |
2023-05-09 Sale | 2023-05-11 5:04 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 60,000 | $94.89 | $5,693,371 | 842,006 (Indirect Direct) | View |
2023-04-10 Sale | 2023-04-12 4:08 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 10,000 | $99.56 | $995,600 | 802,559 (Indirect Direct) | View |
2023-04-06 Sale | 2023-04-10 7:00 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 10,000 | $96.13 | $961,300 | 812,559 (Indirect Direct) | View |
2023-04-03 Sale | 2023-04-04 7:59 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 8,500 | $97.09 | $825,265 | 28,950 (Direct) | View |
2023-03-10 Sale | 2023-03-14 7:40 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 23,000 | $91.64 | $2,107,800 | 1,041,649 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-04-28 Option Award | 2023-08-17 3:57 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer | 318 | $66.88 | 60,804 (Direct) | View |
2023-06-29 Tax Withholding | 2023-06-30 11:35 am | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer | 5,178 | $88.93 | 45,805 (Direct) | View |
2023-05-23 Option Award | 2023-05-24 6:29 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Slamon Dennis Director | 4,190 | $0 | 30,809 (Direct) | View |
2023-05-23 Option Award | 2023-05-24 6:28 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | PYOTT DAVID E I Director | 4,190 | $0 | 45,030 (Direct) | View |
2023-05-23 Option Award | 2023-05-24 6:27 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | MEIER RICHARD A Director | 4,190 | $0 | 115,547 (Direct) | View |
2023-05-23 Option Award | 2023-05-24 6:27 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 4,190 | $0 | 33,140 (Direct) | View |
2023-05-23 Option Award | 2023-05-24 6:26 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | HOMBACH ROBERT J. Director | 4,190 | $0 | 30,500 (Direct) | View |
2023-05-23 Option Award | 2023-05-24 6:26 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Ho Maykin Director | 4,190 | $0 | 16,640 (Direct) | View |
2023-05-23 Option Award | 2023-05-24 6:25 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | HERON ELAINE J Director | 4,190 | $0 | 92,121 (Direct) | View |
2023-05-23 Option Award | 2023-05-24 6:24 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Dere Willard H Director | 4,190 | $0 | 27,580 (Direct) | View |
2023-05-23 Option Award | 2023-05-24 6:24 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | ANDERSON ELIZABETH M Director | 4,190 | $0 | 23,080 (Direct) | View |
2023-05-23 Option Award | 2023-05-24 6:23 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Alles Mark J Director | 4,190 | $0 | 15,095 (Direct) | View |
2023-05-16 Tax Withholding | 2023-05-18 5:31 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Burkhart Erin GVP, Chief Accounting Officer | 796 | $92.02 | 14,094 (Direct) | View |
2023-04-28 Option Award | 2023-05-18 5:19 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer | 317 | $66.88 | 80,474 (Direct) | View |
2023-05-16 Gift | 2023-05-18 5:19 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer | 210 | $0 | 80,474 (Direct) | View |
2023-05-12 Exercise | 2023-05-17 6:14 pm | 2013-08-15 2023-05-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | MEIER RICHARD A Director | 8,500 | $0 | 111,357 (Direct) | View |
2023-05-12 Tax Withholding | 2023-05-17 6:14 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | MEIER RICHARD A Director | 6,137 | $93.93 | 111,357 (Direct) | View |
2023-05-12 Exercise | 2023-05-17 6:14 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | MEIER RICHARD A Director | 8,500 | $67.81 | 111,357 (Direct) | View |
2023-05-12 Exercise | 2023-05-17 6:14 pm | 2013-08-15 2023-05-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | HERON ELAINE J Director | 8,500 | $0 | 87,931 (Direct) | View |
2023-05-12 Tax Withholding | 2023-05-17 6:14 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | HERON ELAINE J Director | 6,137 | $93.93 | 87,931 (Direct) | View |
2023-05-12 Exercise | 2023-05-17 6:14 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | HERON ELAINE J Director | 8,500 | $67.81 | 87,931 (Direct) | View |
2023-05-12 Exercise | 2023-05-16 5:22 pm | 2013-11-15 2023-05-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 46,500 | $0 | 680,265 (Direct) | View |
2023-05-12 Tax Withholding | 2023-05-16 5:22 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 39,981 | $93.93 | 680,265 (Direct) | View |
2023-05-12 Exercise | 2023-05-16 5:22 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 46,500 | $67.81 | 680,265 (Direct) | View |
2023-05-11 Exercise | 2023-05-15 4:58 pm | 2013-11-15 2023-05-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 30,000 | $0 | 712,876 (Direct) | View |
2023-05-11 Exercise | 2023-05-15 4:58 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 30,000 | $67.81 | 712,876 (Direct) | View |
2023-05-09 Exercise | 2023-05-11 5:04 pm | 2013-11-15 2023-05-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 60,000 | $0 | 842,006 (Direct) | View |
2023-04-28 Option Award | 2023-05-11 5:04 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 317 | $66.88 | 842,006 (Direct) | View |
2023-05-09 Exercise | 2023-05-11 5:04 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 60,000 | $67.81 | 842,006 (Direct) | View |
2023-04-28 Option Award | 2023-05-08 4:20 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer | 239 | $66.88 | 45,401 (Direct) | View |
2023-05-04 Tax Withholding | 2023-05-08 4:20 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer | 4,302 | $95.45 | 45,401 (Direct) | View |
2023-04-10 Exercise | 2023-04-12 4:08 pm | 2013-11-15 2023-05-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 10,000 | $0 | 802,559 (Direct) | View |
2023-04-10 Exercise | 2023-04-12 4:08 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 10,000 | $67.81 | 802,559 (Direct) | View |
2023-04-06 Exercise | 2023-04-10 7:00 pm | 2013-11-15 2023-05-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 10,000 | $0 | 812,559 (Direct) | View |
2023-04-06 Exercise | 2023-04-10 7:00 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 10,000 | $67.81 | 812,559 (Direct) | View |
2023-04-03 Exercise | 2023-04-04 7:59 pm | 2013-11-15 2023-05-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 8,500 | $0 | 28,950 (Direct) | View |
2023-04-03 Exercise | 2023-04-04 7:59 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 8,500 | $67.81 | 28,950 (Direct) | View |
2023-03-15 Option Award | 2023-03-17 9:47 pm | 2024-03-15 2033-03-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer | 29,220 | $0 | 69,784 (Direct) | View |
2023-03-15 Tax Withholding | 2023-03-17 9:47 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer | 1,856 | $87.74 | 69,784 (Direct) | View |
2023-03-15 Option Award | 2023-03-17 9:42 pm | 2024-03-15 2033-03-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer | 31,600 | $0 | 77,555 (Direct) | View |
2023-03-16 Tax Withholding | 2023-03-17 9:42 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer | 3,973 | $93.41 | 77,555 (Direct) | View |
2023-03-15 Tax Withholding | 2023-03-17 9:42 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer | 2,708 | $87.74 | 77,555 (Direct) | View |
2023-03-15 Option Award | 2023-03-17 9:37 pm | 2024-03-15 2033-03-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D | 55,290 | $0 | 226,637 (Direct) | View |
2023-03-16 Tax Withholding | 2023-03-17 9:37 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D | 36,000 | $93.41 | 226,637 (Direct) | View |
2023-03-15 Tax Withholding | 2023-03-17 9:37 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D | 4,799 | $87.74 | 226,637 (Direct) | View |
2023-03-15 Option Award | 2023-03-17 9:31 pm | 2024-03-15 2033-03-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer | 29,220 | $0 | 100,687 (Direct) | View |
2023-03-16 Tax Withholding | 2023-03-17 9:31 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer | 19,957 | $93.41 | 100,687 (Direct) | View |
2023-03-15 Tax Withholding | 2023-03-17 9:31 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer | 3,025 | $87.74 | 100,687 (Direct) | View |
2023-03-15 Option Award | 2023-03-17 9:26 pm | 2024-03-15 2033-03-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | Burkhart Erin GVP, Chief Accounting Officer | 9,480 | $0 | 20,610 (Direct) | View |
2023-03-15 Option Award | 2023-03-17 9:22 pm | 2024-03-15 2033-03-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 85,530 | $0 | 722,859 (Direct) | View |
2023-03-16 Tax Withholding | 2023-03-17 9:22 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 88,623 | $93.41 | 722,859 (Direct) | View |
2023-03-15 Tax Withholding | 2023-03-17 9:22 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 9,437 | $87.74 | 722,859 (Direct) | View |
2023-03-15 Option Award | 2023-03-17 9:16 pm | 2024-03-15 2033-03-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer | 33,180 | $0 | 88,556 (Direct) | View |
2023-03-16 Tax Withholding | 2023-03-17 9:16 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer | 20,510 | $93.41 | 88,556 (Direct) | View |
2023-03-15 Tax Withholding | 2023-03-17 9:16 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer | 3,971 | $87.74 | 88,556 (Direct) | View |
2023-03-10 Exercise | 2023-03-14 7:40 pm | 2013-11-15 2023-05-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 23,000 | $0 | 1,041,649 (Direct) | View |
2023-03-10 Exercise | 2023-03-14 7:40 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 23,000 | $67.81 | 1,041,649 (Direct) | View |
2023-02-28 Option Award | 2023-03-02 4:10 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer | 24,890 | $0 | 52,636 (Direct) | View |
2023-02-28 Option Award | 2023-03-02 4:10 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer | 37,724 | $0 | 94,449 (Direct) | View |
2023-02-28 Option Award | 2023-03-02 4:09 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer | 38,769 | $0 | 79,857 (Direct) | View |
2023-02-28 Option Award | 2023-03-02 4:08 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D | 68,052 | $0 | 212,146 (Direct) | View |
2023-02-28 Option Award | 2023-03-02 4:07 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer | 167,532 | $0 | 735,389 (Direct) | View |